2. Why Rural Markets???
India’s growth trajectory is highly driven by the development of the
rural population
For many years, rural India was not much acknowledged by the
pharmaceuticals companies
But as the ‘bottom of the pyramid’ is getting empowered with
education, higher purchasing power and awareness, companies are
looking for opportunities
Players in various industries such as retail, FMCG, pharmaceuticals,
consumer durables, automobiles etc, are looking towards the untapped
potential of these markets
4. Key Points
IPM is doubling every 5 years
Growth factors:
Old products
New products
Price
Acute shortage of new launch options
Increased contribution from hospital segment
Focus of extra urban segment
5. Key Players
Mankind Pharma
Abbott Healthcare
Dr. Reddys Lab
Ranbaxy Labs
Glenmark Pharma
Sanofi Aventis
Fresenius Kabi India
The rural market is also cluttered with local generic players
6. Model
Head Quarters: Class I to Class III towns
Doctor: All Doctors
Products: All fast moving molecules
High thrust on Prescription generation
Price Advantage
Retails Schemes
7. Strategy & Tactics
Visual Aids must be designed with simple and eye-catching text &
images, if possible in local language
Promoting brands in local medical publications or in the local
associations publication
Detailing and educating the doctors enhance the relationship, organize
GP Meets (Audio/Visual) campaigns
Pricing & packaging to suit the GP and Rural markets (Low Value/Low
Volume packaging)
8. Target Audience
General Practitioners (MBBS & Non-MBBS)
RMPs / PMPs
Primary Healthcare Centers
Govt. Dispensaries
Major Rural chemists (Having self practice)
All Doctors in Class III HQs
9. Challenges
Pricing – Highly price dependent, hence need to be as par or lower
than competitors
Recruitment - shortage of skilled manpower
Attrition
Low brand Loyalty
Trade Discounts / Schemes – Chemists dominate the markets
Profitability – Time to reach break-even are delayed due to low margins